About C4 Therapeutics Inc
Clinical-stage biotech company transforming how disease is treated through targeted protein degradation science
- Industry
- Biotechnology
- Company size
- 51-200 employees
- Headquarters
- Watertown, MA
- Founded
- 2015
- Company type
- Public Company
- Company profile name
- C4 Therapeutics, Inc.
C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. C4T is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO® platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. C4T’s degrader medicines are designed to harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve patient outcomes.
Specialties
- biotechnology
- cell biology
- protein chemistry
- cell pharmacology
- and Protein Degradation
Company locations
490 Arsenal Way, Suite #120, Watertown, MA 02472, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
Business areas
- Health Diagnostics
- Biotechnology
- Medical
- Therapeutics
On LinkedIn
- Followers
- 19,298
- People linked to this company
- 114
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
573,800,000 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.